NEW YORK, Dec. 29, 2015 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL). Such investors are advised to contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz at email@example.com or 212-697-6484.
This investigation concerns whether Anavex and certain of its officers and/or directors have violated the Federal Securities Laws under the Securities Exchange Act of 1934 (the "Exchange Act").
Anavex, the clinical-stage biopharmaceutical company that designs therapeutic treatments of neurodegenerative diseases, reported their year-end results for fiscal year 2015. On December 29, 2015, pre-market, the company disclosed that on December 22, 2015 the U.S. Securities and Exchange Commission had subpoenaed the company. Anavex stated, in part, that "[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares."
Following this news, on December 29, 2015, Anavex stock opened at $5.96 from a previous close of $7.03, and in early trading dropped as low $5.54, or 21.19% on heavy volume.
If you are aware of any facts relating to this investigation, or purchased shares of American Capital, Ltd., you can assist this investigation by contacting Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | email@example.com
SOURCE Bronstein, Gewirtz & Grossman, LLC